Elexacaftor-Tezacaftor-Ivacaftor Therapy for Chronic Sinus Disease in Cystic Fibrosis

This cohort study quantifies the 1-year outcomes of elexacaftor-tezacaftor-ivacaftor therapy for chronic rhinosinusitis based on changes in sinus computed tomography using the Lund-Mackay and Sheikh-Lind scoring systems among individuals with cystic fibrosis.
Source: JAMA Otolaryngology - Head and Neck Surgery - Category: ENT & OMF Source Type: research